Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

News: Childhood Cancer

Hyundai Hope On Wheels bolsters pediatric cancer fight

Thursday, July 30th, 2015

Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies. Hyundai Hope […]

Young professionals bolster cancer research efforts

Thursday, July 23rd, 2015

With a basketball tucked under his arm, 7-year-old Roger Waynick climbed on top of his dad’s black Tahoe SUV with the intention of sailing upward through the air toward the basketball goal. He was poised to make the most epic dunk ever. Instead he fell to the ground. “I was told that my dad administered […]

Kitko to lead Pediatric Stem Cell Transplant Program

Thursday, July 16th, 2015

Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology. “We are thrilled to have Dr. Kitko join our faculty and lead our stem cell transplant program,” said Debra Friedman, M.D., director of Pediatric […]

Daniels receives grant to study retinoblastoma treatment

Monday, June 29th, 2015

Anthony Daniels, M.D., M.S.c., assistant professor of Ophthalmology and Visual Sciences, Cancer Biology, and Radiation Oncology at Vanderbilt University Medical Center (VUMC), recently received a career-starter research grant from the Knights Templar Eye Foundation for $60,000. The funds will allow Daniels, also director of Ocular Oncology at the Vanderbilt Eye Institute, and his team to further […]

American Surgical Association lauds VUMC’s Beauchamp

Thursday, May 14th, 2015

R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences and the John Clinton Foshee Distinguished Professor of Surgery, was selected to receive the 2015 Flance-Karl Award from the American Surgical Association (ASA). Beauchamp, who is also a professor of Surgery, Cancer Biology and Cell and Developmental Biology, traveled to San Diego last week […]

NCI report shows U.S. cancer deaths on decline

Thursday, April 2nd, 2015

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. The report from the National Cancer Institute, a division of the National Institutes of Health, […]

New Approach for Treating Retinoblastoma

Thursday, October 9th, 2014

Vanderbilt doctors are using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo, to treat retinoblastoma, the most common ocular cancer in children.

Childhood Cancer Investigator Lands ‘Lemonade Stand’ Grant

Thursday, July 12th, 2012

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. The two-year Innovation Award from Alex’s Lemonade Stand Foundation (ALSF) will help fund Chiang’s research on rhabdomyosarcoma (RMS), the most common soft tissue malignancy […]

Going for the Gold

Tuesday, April 17th, 2012

Vanderbilt-Ingram Cancer Center cordially invites you and your guests to join us for Going for the Gold: Living Well through Cancer! Due to an overwhelming response, we have closed registration. We are thrilled to have so many people attend! Date: Saturday, June 30, 2012 Time: 9:30 a.m.-2:30 p.m. Where: Vanderbilt University Student Life Center 310 […]

When Childhood Cancer Survivors Have Children

Monday, January 2nd, 2012

A large, retrospective study of the children of childhood cancer survivors who were treated with radiation therapy and/or some forms of chemotherapy found that the offspring do not have an increased risk for birth defects compared to children of cancer survivors who did not receive these treatments. The findings provide reassurance that increased risks of […]

Next Page »